PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 39 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $41,000 | -71.9% | 231,900 | -4.5% | 0.02% | -71.2% |
Q2 2022 | $146,000 | -54.4% | 242,900 | +0.2% | 0.08% | -48.1% |
Q1 2022 | $320,000 | -51.3% | 242,473 | -3.7% | 0.15% | -46.7% |
Q4 2021 | $657,000 | -7.9% | 251,723 | +9.8% | 0.29% | -10.5% |
Q3 2021 | $713,000 | -16.4% | 229,223 | -0.1% | 0.32% | -8.0% |
Q2 2021 | $853,000 | +80.0% | 229,373 | +62.6% | 0.35% | +51.9% |
Q4 2020 | $474,000 | +45.4% | 141,025 | +51.7% | 0.23% | +15.5% |
Q3 2020 | $326,000 | +31.5% | 92,950 | +72.2% | 0.20% | +14.9% |
Q2 2020 | $248,000 | +115.7% | 53,974 | +55.3% | 0.17% | +65.7% |
Q1 2020 | $115,000 | – | 34,750 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 1,607,044 | $4,194,000 | 0.48% |
NEA Management Company, LLC | 6,643,704 | $17,340,000 | 0.35% |
Platform Technology Partners | 251,723 | $657,000 | 0.29% |
DAFNA Capital Management LLC | 378,611 | $988,000 | 0.25% |
Avidity Partners Management LP | 4,405,000 | $11,497,000 | 0.24% |
Endurant Capital Management LP | 360,078 | $940,000 | 0.23% |
Rock Springs Capital Management LP | 2,581,299 | $6,737,000 | 0.16% |
RA Capital Management | 2,850,000 | $7,439,000 | 0.13% |
New Legacy Group, LLC | 240,575 | $628,000 | 0.12% |
XTX Topco Ltd | 15,574 | $41,000 | 0.02% |